Augmentin '125' and Restasis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin '125' (amoxicillin; clavulanate potassium) and Restasis (cyclosporine). Common drug interactions include facial pain among females.

The phase IV clinical study analyzes what interactions people have when they take Augmentin '125' and Restasis. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

16 people who take Augmentin '125' and Restasis together, and have interactions are studied.

Augmentin '125' and Restasis drug interactions.

What are the common drug interactions of Augmentin '125' and Restasis, by gender? *:

female:

  1. Facial pain
  2. Cardiac failure congestive
  3. Candidiasis (candidiasis or thrush is a fungal infection)
  4. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  5. Decreased appetite
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Hypokalaemia (low potassium)
  8. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  9. Osteopenia (a condition where bone mineral density is lower than normal)
  10. Pleural fibrosis (formation of fibrous tissue in lung)

male:

n/a

What are the common drug interactions of Augmentin '125' and Restasis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Dysgeusia (disorder of the sense of taste)
  2. Facial pain
  3. Pain in jaw
  4. Addison's disease (addison's disease, a hormonal disorder disease)
  5. Anaemia of chronic disease
  6. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Bone disorder
  9. Candidiasis (candidiasis or thrush is a fungal infection)
  10. Cardiac arrest

60+:

  1. Abdominal pain
  2. Anxiety
  3. Adenomatous polyposis coli ((fap) is an inherited condition in which numerous polyps form mainly in the epithelium of the large intestine)
  4. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  5. Anaemia (lack of blood)
  6. Antiphospholipid antibodies positive
  7. Aortic valve sclerosis (narrowing of the aortic valve)
  8. Asthenia (weakness)
  9. Atelectasis (partial or complete collapse of the lung)
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 9 people, 56.25%
  2. Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 9 people, 56.25%
  3. Hypercalcaemia (elevated calcium (ca+) level in the blood): 7 people, 43.75%
  4. Skin Wrinkling (wrinkle on skin): 2 people, 12.50%
  5. Rosacea (a skin condition that causes facial redness): 2 people, 12.50%
  6. Nerve Block (the interruption of signals travelling along a nerve): 2 people, 12.50%
  7. Eyelid Twitch (spontaneous and uncontrolled spasms of the muscles): 2 people, 12.50%
  8. Anaesthesia: 2 people, 12.50%
  9. Sinusitis (inflammation of sinus): 1 person, 6.25%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '125' and Restasis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Augmentin '125' and Restasis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin '125':

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Restasis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin '125' and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Restasis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and cyclosporine (the active ingredients of Augmentin '125' and Restasis, respectively), and Augmentin '125' and Restasis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: